glp 1 shortage guidance Joint PCDS and ABCD guidance: GLP-1 receptor agonist national GLP-1 receptor agonist shortage expected

Discovery, characterization, and clinical development of the glucagon-like peptides

Stopping GLP1-RAs without a management plan may lead to worsening control of diabetes and excessive weight gain, both of which are associated with pregnancy complications

Effect of phosphodiesterase-type 5 inhibitors on erectile function: An overview of systematic reviews and meta-analyses

Obes Rev 2015;16:621638

The study was sponsored by Eli Lilly, the maker of Mounjaro and Zepbound

For individuals exploring weight management and metabolic health, understanding the difference between herbal metabolic support and evidence-based pharmaceutical options matters